Drug Addiction | Klarity Life

Drug Addiction

A 2015 survey found that over 21 million Americans suffer from some form of substance use disorder and, more frightening still, 63,600 people died from drug overdoses in 2016. These numbers are expected to rise as opioid addiction continues to increase. At The Clinic at Klarity Life, Dr. Henry Liang understands the need for long-term solutions for drug addiction, which is why he offers ketamine and NAD+ infusion therapy. This unique approach helps patients maintain their sobriety from stimulants, opiates, and benzodiazepines by controlling their cravings. If you’d like to explore how these medicines can help get you on the road to recovery, contact us.
1What is drug addiction?
Drug addiction is a chronic disease that compels people to use drugs in a way that’s harmful to their health. The reason this happens is because a drug addiction rewires your brain, creating new pathways that are designed solely for drug use.

These pathways are created after your brain experiences the pleasurable effects of a drug and it adjusts itself to receive more. This, in turn, prompts you to use more of the drug in an effort to satisfy the bottomless pit that is addiction.

Drug addiction is a very serious disease that has physical, social, and mental health consequences.
2What are the signs of drug addiction?
Drug addiction carries with it two components: dependency and addiction. The dependency aspect is when your body physically needs the drug and goes into withdrawal when it’s not available. The addiction component leads to obsessive cravings and uncontrolled use. It is also associated with behaviors that can be destructive and life threatening. Combined, these two components often lead to:

• Physical withdrawal, such as the shakes or flu-like symptoms, or worse
• The inability to control use
• Poor performance at work or school
• Isolation
• Choosing your drug of choice over other activities
• Financial issues
• Difficulty in relationships with friends and family
• Depression and Suicide

There’s very little in your life that drug addiction doesn’t affect, which is why treatments designed for long-term abstinence work best.
3How do NAD+ and ketamine therapy help drug addiction?
Dr. Liang recommends NAD+ and ketamine infusion therapy in order to address:

Post-acute withdrawal syndrome (PAWS)
PAWS can affect you weeks, months, and even years after you stop using the drug. Symptoms include depression, anxiety, irritability, sleep disturbances, and impaired cognition. By rapidly creating new neural connections, ketamine and NAD+ combination therapy dramatically eliminates or reduces these symptoms.

The new pathways established by your drug use continue to demand more of the drug, which leads to cravings. Ketamine and NAD+ combination therapy disrupts these pathways and creates new ones.

Ketamine works quickly on these problems, sometimes after just one treatment, as new connections are formed in your brain that bypasses the addiction. Ketamine and NAD+ therapy is especially useful in helping you maintain your sobriety, leading a life that’s free from the bonds of drug addiction.

Similar to alcohol addiction, ketamine and NAD+ combination therapy are extremely effective in the detoxification process from stimulants, opiates, benzodiazepines, and kratom. NAD+ is especially effective at reducing the oxidative stress at the cellular level that occurs during detoxification.

To learn more about how ketamine can help you overcome your drug addiction, contact Klarity Life.

Management & Maintenance

Ketamine and NAD+ therapy has been successfully used in the management and maintenance of life free of drugs and alcohol. This combination is effective for both detoxification and afterwards to control or eliminate the urge to use again. Coupled with therapy and recovery support, ketamine and NAD+ infusion therapy can help you transition to and maintain a healthy sober lifestyle.


Other conditions that may benefit from ketamine and NAD+ therapy


Other conditions that may benefit from ketamine and NAD+ therapy